Friday - February 06, 2026

Chronic Lower Back Pain Therapeutics Market Size in the 7MM was approximately USD 6,071 million in 2023, estimates DelveInsight

Chronic Lower Back Pain Market CLBP companies are Eli Lilly and Company, Collegium Pharmaceutical, Purdue Pharma LP, BioDelivery Sciences International, Camurus, Braeburn Inc., Scilex Holding, Mesoblast Limited, AnGes MG, Inc., Kolon Life Science, Eliem Therapeutics, Allodynic Therapeutics, Sollis Therapeutics, Medtronic … Continue reading

Epilepsy Treatment Pipeline Shows Strong Momentum as 75+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Epilepsy Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 90+ pipeline drugs in the Epilepsy pipeline landscape. It covers the Epilepsy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Epilepsy pipeline … Continue reading

Brutons Tyrosine Kinase Inhibitors Treatment Pipeline Shows Strong Momentum as 30+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Brutons Tyrosine Kinase Inhibitors Pipeline Insight 2025” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in the Brutons Tyrosine Kinase Inhibitors pipeline landscape. It covers the Brutons Tyrosine Kinase Inhibitors pipeline drug profiles, including clinical and … Continue reading

Facioscapulohumeral Muscular Dystrophy Market Size in the 7MM is projected to grow at a significant CAGR by 2034, estimates DelveInsight

DelveInsight’s “Facioscapulohumeral Muscular Dystrophy Market Insights, Epidemiology and Market Forecast – 2034” report delivers an in-depth understanding of facioscapulohumeral muscular dystrophy, historical and forecasted epidemiology as well as the facioscapulohumeral muscular dystrophy market trends in the United States, EU4 (Germany, … Continue reading

Gastroesophageal Reflux Disease Treatment Pipeline Shows Strong Momentum as 10+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Gastroesophageal Reflux Disease Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Gastroesophageal Reflux Disease (GERD) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading

Acoustic Neuroma Market Outlook 2025-2034: Increasing Incidence and Novel Treatments to Shape Future Growth, analyses DelveInsight

Acoustic Neuroma Market The Acoustic Neuroma market is projected to grow at a significant CAGR from 2020 to 2034, driven by improved diagnosis, an aging population, and advances in treatment technologies. Increased MRI use is leading to earlier and more … Continue reading

Acute Coronary Syndrome Treatment Pipeline Shows Strong Momentum as 5+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Acute Coronary Syndrome Pipeline Insight 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in the Acute Coronary Syndrome pipeline landscape. It covers the Acute Coronary Syndrome pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading